The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients

Breast Cancer Research and Treatment

Volumn 126, Issue 2, 2011, Pages 471-478

  Bae, Soo Youn ^a   Lee, Se Kyung ^a   Koo, Min Young ^a   Hur, Sung Mo ^a   Choi, Min Young ^a   Cho, Dong Hui ^a   Kim, Sangmin ^a   Choe, Jun Ho ^a   Lee, Jeong Eon ^a   Kim, Jung Han ^a   Kim, Jee Soo ^a   Nam, Seok Jin ^a   Yang, Jung Hyun ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Adjuvant chemotherapy; Invasive ductal carcinoma; Metaplastic breast cancer; Prognosis; Triple negative breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METAPLASIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KERATINS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; MIXED TUMOR, MALIGNANT; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79958743284     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1359-8     Document Type: Article

References (22)

1. Oberman HA (1987) Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 11:918-929 (Pubitemid 18011643)
2. Tavassoli FA (1992) Classification of metaplastic carcinomas of the breast. Pathol Annu 27(Pt 2):89-119
3. Huvos AG, Lucas JC Jr, Foote FW Jr (1973) Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med 73:1078-1082
4. Grechi G, Pagnini P (1965) Study of mammary gland neoplasms with an osteocartilaginous component. I. Cartilaginous metaplastic epiphenomena in the course of connective tissue malignancy. Arch De Vecchi Anat Patol 46:277-303
5. Tavassoli FA, Devilee P (2003) World health organization: Tumours of the breast and female genital organs. Oxford University, Oxfordshire
6. Wargotz ES, Deos PH, Norris HJ (1989) Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol 20:732-740 (Pubitemid 19203633)
7. Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 64:1490-1499 (Pubitemid 19238967)
8. Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 20:628-635 (Pubitemid 19185291)
9. Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast: V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol 21:1142-1150 (Pubitemid 20381997)
10. Wargotz ES, Norris HJ (1990) Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer 65:272-276 (Pubitemid 20035352)
11. Beatty JD, Atwood M, Tickman R, Reiner M (2006) Metaplastic breast cancer: clinical significance. Am J Surg 191:657-664
12. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K (2007) Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol 14:166-173 (Pubitemid 44954285)
13. Gutman H, Pollock RE, Janjan NA, Johnston DA (1995) Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 180:193-199
14. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63:181-187 (Pubitemid 19032001)
15. Lim KH, Oh DY, Chie EK, Han W, Im SA, Kim TY, Park IA, Noh DY, Ha SW, Bang YJ (2010) Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity. Jpn J Clin Oncol 40:112-118
16. Jung SY, Kim HY, Nam BH, Min SY, Lee SJ, Park C, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J (2010) Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat 120:627-637
17. Barnes PJ, Boutilier R, Chiasson D, Rayson D (2005) Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 91:173-178 (Pubitemid 40684929)
18. Khan HN, Wyld L, Dunne B, Lee AH, Pinder SE, Evans AJ, Robertson JF (2003) Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol 29:600-603 (Pubitemid 37121761)
19. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-752
20. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, Trudel M, Akslen LA (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482-1485 (Pubitemid 37279334)
21. Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM (2006) Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 19:264-271 (Pubitemid 43117611)
22. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA (2007) Triplenegative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13:4429-4434 (Pubitemid 47219710)